Thank you for your question. The medication value sets developed for the program contain RxNorm codes that are Semantic Clinical Drugs (SCD), generic, and prescribable. We explicitly exclude brand name drugs from the value sets. In order to satisfy the measure, you would need to map your local brand name drugs to the appropriate generic code. This value set does contain the SCD RxNorm codes for warfarin, heparin and enoxaparin. Dipyridamole by itself is not sufficient for antithrombotic use for stroke patients. If you need more information on RxNorm codes included in value sets, you can reference the Blueprint for the CMS Measures Management System located here: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/Downloads/Blueprint-130.pdf Section 17.1.4.4.4 RxNorm Use in Quality Measures  

The aspirin/anti-thrombotic value set missing branded medication Rx Norm codes, it only has codes for generic medications. Also it is missing some common anti-thrombotic meds--warfarin, heparin, enoxaparin, and dipyridamole. eCQM and UDS reporting is inaccurate.